Improved Leverage and Balance Sheet
Net debt to credit-adjusted EBITDA improved to 2.6x (from 3.8x in 2024); gross debt reduced to ~$6.0B (down nearly $3.0B vs 2024); cash & equivalents of $590M.
Consolidated Profitability Expansion
Full-year EBITDA grew ~7% with ~100 basis points of EBITDA margin expansion; Q4 EBITDA was $437M, a ~7% increase, and Q4 EBITDA margin improved ~90 basis points to 16.9%.
Taste Segment Strength
Full-year Taste sales up ~4% (two-year avg growth ~4%); Q4 Taste sales $588M (+2%) with Q4 EBITDA up ~17% to $94M, driven by new wins, favorable net pricing and productivity.
Health & Biosciences Momentum
Full-year Health & Biosciences sales improved (management cited ~3% full-year improvement) with EBITDA up ~7% for the year; Q4 sales $589M (+5%) and Q4 EBITDA increased ~20% to $155M, led by Food Biosciences, Animal Nutrition and Home & Personal Care.
Scent Performance and Higher‑Value Mix
Full-year Scent sales +3% with EBITDA +2%; Q4 Scent sales $610M (+4%): Fine Fragrance +10% and Consumer Fragrance mid-single-digit growth, indicating strength in higher-margin areas.
Food Ingredients Margin Improvement (Full Year)
Although full-year Food Ingredients sales were down, the business delivered ~10% EBITDA growth and ~150 basis points of EBITDA margin expansion for the full year, reflecting margin improvement through portfolio actions and productivity.
Active Portfolio Optimization
Completed divestitures (Pharma Solutions, nitrocellulose, René Laurent), agreement to sell soy crush concentrates & lecithin to Bunge (expected by April), and formally launched a competitive sale process for Food Ingredients with meaningful interest from strategics and financial sponsors.
Investment in Innovation and Capacity
Invested ~ $100M in R&D in 2025; CapEx totaled $594M (~5.5% of sales) in 2025 and planned CapEx ~6% of sales in 2026; launched new technologies (EnviroCAPS biodegradable encapsulation, 'Super Carrot' umami ingredient) and are investing in enzyme capacity, naturals, biotech and AI.
Cash Return & Capital Allocation Discipline
Returned $409M via dividends and $38M in share repurchases (program started in Q4); management intends to use potential Food Ingredients sale proceeds to reduce dilution and pay down debt while keeping net leverage below 3.0x.